Firefly Neuroscience Inc
AIFF1.580USD
+0.070+4.64%
Close 11/21, 16:00（ET）Quotes delayed by 15 min
21.29MMarket Cap
LossP/E TTM
More Details of Firefly Neuroscience Inc Company
Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company dedicated to developing neuroscientific solutions that enhance outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics (BNA) software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder (ADHD). BNA, utilizing AI and an extensive proprietary electroencephalogram (EEG) database, combines the automatic analysis of Event Related Potentials (ERPs), spectral EEG and behavioral performance data for a comprehensive, and objective data-driven brain health evaluation. The BNA Platform, in conjunction with an FDA-cleared EEG system, can provide clinicians with comprehensive insights into brain function (cognition).
Firefly Neuroscience Inc Info
Ticker SymbolAIFF
Company nameFirefly Neuroscience Inc
IPO dateOct 27, 1993
CEOMr. Greg Lipschitz
Number of employees13
Security typeOrdinary Share
Fiscal year-endOct 27
Address1100 Military Road
CityKENMORE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code14217
Phone18882376412
Websitehttps://fireflyneuro.com/
Ticker SymbolAIFF
IPO dateOct 27, 1993
CEOMr. Greg Lipschitz
Company Executives of Firefly Neuroscience Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Gil Issachar
Mr. Gil Issachar
Chief Technology Officer
Chief Technology Officer
33.48K
--
Mr. David (Dave) Decaprio
Mr. David (Dave) Decaprio
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
11.00K
-0.90%
Mr. Paul Krzywicki, CPA
Mr. Paul Krzywicki, CPA
Chief Financial Officer
Chief Financial Officer
2.50K
--
Mr. Stephen Kilmer
Mr. Stephen Kilmer
Investor Contact
Investor Contact
--
--
Mr. Greg Lipschitz
Mr. Greg Lipschitz
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Brian M. Posner, CPA
Mr. Brian M. Posner, CPA
Independent Director
Independent Director
--
--
Ms. Stella Vnook
Ms. Stella Vnook
Independent Director
Independent Director
--
--
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Gil Issachar
Mr. Gil Issachar
Chief Technology Officer
Chief Technology Officer
33.48K
--
Mr. David (Dave) Decaprio
Mr. David (Dave) Decaprio
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
11.00K
-0.90%
Mr. Paul Krzywicki, CPA
Mr. Paul Krzywicki, CPA
Chief Financial Officer
Chief Financial Officer
2.50K
--
Mr. Stephen Kilmer
Mr. Stephen Kilmer
Investor Contact
Investor Contact
--
--
Mr. Greg Lipschitz
Mr. Greg Lipschitz
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Brian M. Posner, CPA
Mr. Brian M. Posner, CPA
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: 13 hours ago
Updated: 13 hours ago
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Johnson (David Ian)
8.28%
Windsor Private Capital LP
8.18%
The Vanguard Group, Inc.
3.73%
RJL 18 Capital Canada LP
3.70%
Lipschitz (Gregory)
3.20%
Other
72.91%
Shareholders
Shareholders
Proportion
Johnson (David Ian)
8.28%
Windsor Private Capital LP
8.18%
The Vanguard Group, Inc.
3.73%
RJL 18 Capital Canada LP
3.70%
Lipschitz (Gregory)
3.20%
Other
72.91%
Shareholder Types
Shareholders
Proportion
Corporation
15.54%
Individual Investor
15.15%
Investment Advisor/Hedge Fund
7.07%
Investment Advisor
5.72%
Bank and Trust
0.16%
Research Firm
0.04%
Hedge Fund
0.02%
Other
56.29%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
41
1.85M
13.77%
+1.37M
2025Q2
56
6.51M
49.12%
+3.62M
2025Q1
59
6.44M
48.97%
+3.40M
2024Q4
45
5.34M
66.51%
+3.29M
2024Q3
44
4.63M
60.12%
+4.34M
2024Q2
41
392.29K
19.12%
-172.61K
2024Q1
44
378.90K
18.56%
-204.63K
2023Q4
44
402.68K
20.26%
-97.56K
2023Q3
43
439.70K
22.73%
-157.24K
2023Q2
43
553.83K
29.34%
-60.70K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Johnson (David Ian)
1.12M
8.3%
+557.88K
+100.00%
Oct 22, 2024
Windsor Private Capital LP
1.71M
12.68%
+182.84K
+12.01%
Sep 04, 2025
The Vanguard Group, Inc.
101.99K
0.76%
--
--
Jun 30, 2025
RJL 18 Capital Canada LP
499.37K
3.71%
+499.37K
--
Aug 13, 2024
Lipschitz (Gregory)
431.20K
3.21%
+11.00K
+2.62%
Sep 04, 2025
Roxy Capital Corp.
424.69K
3.16%
-265.38K
-38.46%
Feb 12, 2025
Finn (Christopher)
349.22K
2.6%
-85.98K
-19.76%
Dec 31, 2024
Geode Capital Management, L.L.C.
120.60K
0.9%
+58.07K
+92.85%
Jun 30, 2025
Menawat (Arun Swarup Ph.D.)
99.41K
0.74%
--
--
Sep 04, 2025
BlackRock Institutional Trust Company, N.A.
14.44K
0.11%
+14.44K
--
Jun 30, 2025
View more
Related ETFs
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Oct 17, 2023
Merger
10→1
Oct 17, 2023
Merger
10→1
Oct 17, 2023
Merger
10→1
Oct 17, 2023
Merger
10→1
Date
Type
Ratio
Oct 17, 2023
Merger
10→1
Oct 17, 2023
Merger
10→1
Oct 17, 2023
Merger
10→1
Oct 17, 2023
Merger
10→1
FAQs
Who are the top five shareholders of Firefly Neuroscience Inc?
The top five shareholders of Firefly Neuroscience Inc are:
Johnson (David Ian) holds 1.12M shares, accounting for 8.30% of the total shares.
Windsor Private Capital LP holds 1.71M shares, accounting for 12.68% of the total shares.
The Vanguard Group, Inc. holds 101.99K shares, accounting for 0.76% of the total shares.
RJL 18 Capital Canada LP holds 499.37K shares, accounting for 3.71% of the total shares.
Lipschitz (Gregory) holds 431.20K shares, accounting for 3.21% of the total shares.
Johnson (David Ian) holds 1.12M shares, accounting for 8.30% of the total shares.
Windsor Private Capital LP holds 1.71M shares, accounting for 12.68% of the total shares.
The Vanguard Group, Inc. holds 101.99K shares, accounting for 0.76% of the total shares.
RJL 18 Capital Canada LP holds 499.37K shares, accounting for 3.71% of the total shares.
Lipschitz (Gregory) holds 431.20K shares, accounting for 3.21% of the total shares.
What are the top three shareholder types of Firefly Neuroscience Inc?
The top three shareholder types of Firefly Neuroscience Inc are:
Johnson (David Ian)
Windsor Private Capital LP
The Vanguard Group, Inc.
Johnson (David Ian)
Windsor Private Capital LP
The Vanguard Group, Inc.
How many institutions hold shares of Firefly Neuroscience Inc (AIFF)?
As of 2025Q3, 41 institutions hold shares of Firefly Neuroscience Inc, with a combined market value of approximately 1.85M, accounting for 13.77% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -35.35%.
What is the biggest source of revenue for Firefly Neuroscience Inc?
In --, the -- business generated the highest revenue for Firefly Neuroscience Inc, amounting to -- and accounting for --% of total revenue.
